Tyruko 300mg / 15ml

7680695030013 CH-69503 15ml
Tyruko 300mg / 15ml
Tyruko 300mg / 15ml
Tyruko 300mg / 15ml
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
15ml
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
12/09/2025
Summary of Product Characteristics
Français
12/09/2025
Summary of Product Characteristics
Italien
12/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
51.73 MG Substance HBESI

Reimbursement information

Public price
CHF 1194.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2025

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
69503
Drug name
Tyruko, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L04AG03
Authorization status
Z
Dispensing category
B
First authorization
05/11/2024
Authorization expiration date
04/11/2029
IT Number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Package details

Description (FR)
TYRUKO conc perf 300 mg/15ml flac 15 ml
Description (DE)
TYRUKO Inf Konz 300 mg/15ml Durchstf 15 ml
Market launch
28/05/2025
Narcotic (BTM)
No